IBXNC
IMAGIONBIO DEF X OPT [IBXNC]
1 day chart
About IBXNC
Imagion Biosystems is developing a new non-radioactive and precision diagnostic molecular imaging technology. Combining biotechnology and nanotechnology, the Company aims to detect cancer and other diseases earlier and with higher specificity than is currently possible.
Buy Australian shares starting with IBXNC. Invest today with a CHESS-sponsored investing platform!
Market Capitalisation
$18M
Price-earnings ratio
0
Dividend yield
0.00%
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Announcements
IBXNC FAQs
Can I buy IBXNC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake platform allows you to buy IBXNC shares and over 8,000 stocks and ETFs across the ASX and Wall St.
How much is one share of IMAGIONBIO DEF X OPT [IBXNC]?
One share of IMAGIONBIO DEF X OPT [IBXNC] is valued at $0.00.
What is the ticker symbol for IMAGIONBIO DEF X OPT [IBXNC]?
The ticker symbol for IMAGIONBIO DEF X OPT [IBXNC] is IBXNC.
How do I buy IBXNC shares in Australia?
To buy IBXNC stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in IBXNC
What is the 52-week high for IMAGIONBIO DEF X OPT [IBXNC] stock?
The IMAGIONBIO DEF X OPT [IBXNC] 52-week high stock price is $NaN.
What is the 52-week low for IMAGIONBIO DEF X OPT [IBXNC] stock?
The IMAGIONBIO DEF X OPT [IBXNC] 52-week low stock price is $NaN.
What is the market capitalisation of IMAGIONBIO DEF X OPT [IBXNC] IBXNC?
As of 16/09/2023 IMAGIONBIO DEF X OPT [IBXNC] has a market cap of $18M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.